NeoADAURA plain language summary.pdf (1.01 MB)
NeoADAURA plain language summary: Neoadjuvant osimertinib with/without chemotherapy vs chemotherapy alone for EGFR mutated resectable NSCLC: NeoADAURA.pdf
figure
posted on 2021-07-20, 13:03 authored by Masahiro Tsuboi, Walter Weder, Carles Escriu, Collin Blakely, Jianxing He, Sanja Dacic, Yasushi Yatabe, Lingmin Zeng, Andrew Walding, Jamie E ChaftPlain Language Summary: Neoadjuvant osimertinib with/without chemotherapy vs chemotherapy alone for EGFR mutated resectable NSCLC: NeoADAURA